IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to ...

The sam® wearable ultrasound biotechnology is purpose-built to treat the most common athletic injuries, accelerating soft tissue healing and reducing the need for surgery or pain medication.TRUMBULL, ...

LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular diseaseOXFORD, ENGLAND / ACCESSWIRE / September 20, 2024 / GENinCode Plc (AIM:GENI), the genetics ...

Each year, the CDC estimates that around 385,000 healthcare workers in the United States suffer from needlestick and ...

The global healthcare landscape is undergoing a profound transformation with the emergence of virtual hospitals, a paradigm ...

Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive agent for its Aversa™ Fentanyl abuse deterrent fentanyl ...

SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care ...

DENVER, CO / ACCESSWIRE / September 19, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its ...

Lisa Ferrara, Ph.D., brings over 30 years of experience in orthopaedic medical device innovation and regulatory strategy in the USA·       Dr Ferrara will play a pivotal role in advancing Renovos’ ...

The Austrian Academy of Sciences (OeAW) is further expanding its focus on life sciences by opening an institute for Biomedical Artificial Intelligence (AI) based on a € 150 million funding from the ...

Hormone therapy is often used to slow the progression of advanced prostate cancer, but some cancers develop resistance and continue to growResearch reveals that advanced prostate cancer patients with ...

Bayer has submitted a Marketing Authorisation Application (MAA) to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for the investigational compound elinzanetant for the treatment ...